Avidity Biosciences
RNAM
#1792
Rank
A$15.83 B
Marketcap
A$102.51
Share price
0.00%
Change (1 day)
91.69%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$15.83 Billion

As of March 2026 Avidity Biosciences has a market cap of A$15.83 Billion. This makes Avidity Biosciences the world's 1792th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$15.83 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$219.88 B 1,288.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$150.72 B 851.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.48 B-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$7.85 B-50.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.18 B-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.15 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.38 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.03 B-74.51%๐Ÿ‡บ๐Ÿ‡ธ USA